GO:0032873

BP

negative regulation of stress-activated MAPK cascade

Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.

MYC, GSTP1, IGBP1, FOXM1, FOXO1, PBK

GO:0032874

BP

positive regulation of stress-activated MAPK cascade

Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.

MID1, ARL6IP5, HMGCR, TGFB2, MAPK8IP2, PDCD10, TAOK3, TAOK2

GO:0032876

BP

negative regulation of DNA endoreduplication

Any process that stops, prevents, or reduces the frequency, rate or extent of DNA endoreduplication.

MRE11A, SMC1A, SMC3

GO:0032877

BP

positive regulation of DNA endoreduplication

Any process that activates or increases the frequency, rate or extent of DNA endoreduplication.

E2F8

GO:0032878

BP

regulation of establishment or maintenance of cell polarity

Any process that modulates the frequency, rate or extent of the specification, formation or maintenance of anisotropic intracellular organization or cell growth patterns.

TEK

GO:0032880

BP

regulation of protein localization

Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location.

WASL, STX6, DNAJB6, RSL1D1, INS, PRNP, MAPK8, RAB9A, RACK1, PICALM, PTCH1, CAMK1, SEPT2, MMD, AAK1, RABGAP1L, BORA, TRIM22, CEP120, TEX15, CELSR3, B9D1

GO:0032886

BP

regulation of microtubule-based process

Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton.

ERBB2, APC, GSK3B, KLHL42, MACF1

GO:0032897

BP

negative regulation of viral transcription

Any process that stops, prevents, or reduces the frequency, rate or extent of viral transcription.

TRIM13, ZFP36, IFITM3, TRIM14, TRIM62, TRIM8

GO:0032900

BP

negative regulation of neurotrophin production

Any process that stops, prevents, or reduces the frequency, rate, or extent of production of a neurotrophin.

ADORA1

GO:0032902

BP

nerve growth factor production

The appearance of nerve growth factor (NGF) due to biosynthesis or secretion by cells in a neuron's target field, resulting in an increase in its intracellular or extracellular levels.

FURIN, PCSK6

GO:0032909

BP

regulation of transforming growth factor beta2 production

Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.

TGFB2, SMAD3, SMAD4, HIF1A

GO:0032911

BP

negative regulation of transforming growth factor beta1 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta1.

FURIN, GATA6

GO:0032912

BP

negative regulation of transforming growth factor beta2 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta2.

GATA6

GO:0032913

BP

negative regulation of transforming growth factor beta3 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta3.

CD24

GO:0032914

BP

positive regulation of transforming growth factor beta1 production

Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta1.

THBS1, LUM, FOXP3

GO:0032916

BP

positive regulation of transforming growth factor beta3 production

Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta3.

CREB1, SMAD3

GO:0032918

BP

spermidine acetylation

The modification of spermidine by addition of acetyl groups.

SAT1, SAT2

GO:0032919

BP

spermine acetylation

The modification of spermine by addition of acetyl groups.

SAT1, SAT2

GO:0032920

BP

putrescine acetylation

The modification of putrescine by addition of acetyl groups.

SAT1, SAT2

GO:0032922

BP

circadian regulation of gene expression

Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours.

ARNTL, BHLHE40, OGT, PER1, USP2, NGFR, TOP1, DRD2, ATF4, NR1D1, KDM5A, RORA, AHR, PPP1CC, NAMPT, NRIP1, CSNK1D, CSNK1E, PPP1CA, PPP1CB, HNRNPU, RELB, ID2, CREM, GFPT1, PPARA, MTA1, HDAC1, NCOA2, ZFHX3, CRY1, CARTPT, HDAC2, PRKCDBP, NPAS2, RBM4B, MYBBP1A, LGR4, PPARGC1A, NOCT

GO:0032924

BP

activin receptor signaling pathway

A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.

BMP10, INHBA, INHBB, ACVR2A, ACVR1B, TGFBR1, SMAD3, ACVR1, ACVR2B, BMPR2, SMAD2

GO:0032925

BP

regulation of activin receptor signaling pathway

Any process that modulates the frequency, rate or extent of the activity of any activin receptor signaling pathway.

SMAD7

GO:0032926

BP

negative regulation of activin receptor signaling pathway

Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.

SKI, FST, SYNJ2BP, ACVR1, MAGI2, LEMD3

GO:0032927

BP

positive regulation of activin receptor signaling pathway

Any process that activates or increases the frequency, rate or extent of the activity of any activin receptor signaling pathway.

ACVR2A, FGF9, ACVR1B, SYNJ2BP, ACVR2B, ZC3H3

GO:0032928

BP

regulation of superoxide anion generation

Any process that modulates the frequency, rate or extent of enzymatic generation of superoxide by a cell.

SYK

GO:0032929

BP

negative regulation of superoxide anion generation

Any process that stops, prevents, or reduces the frequency, rate or extent of enzymatic generation of superoxide by a cell.

AATF

GO:0032930

BP

positive regulation of superoxide anion generation

Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.

EGFR, AGT, TGFB1, CRP, GSTP1, F2RL1, PRKCD

GO:0032933

BP

SREBP signaling pathway

A series of molecular signals from the endoplasmic reticulum to the nucleus generated as a consequence of decreased levels of one or more sterols (and in some yeast, changes in oxygen levels) and which proceeds through activation of a sterol response element binding transcription factor (SREBP) to result in up-regulation of target gene transcription.

INSIG1, ERLIN2

GO:0032940

BP

secretion by cell

The controlled release of a substance by a cell.

SERPINE2, FURIN, PCSK6, TYRO3, MERTK, CKLF

GO:0032943

BP

mononuclear cell proliferation

The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form.

TGFB1, ACE

GO:0032945

BP

negative regulation of mononuclear cell proliferation

Any process that stops, prevents, or reduces the frequency, rate or extent of mononuclear cell proliferation.

LILRB1

GO:0032946

BP

positive regulation of mononuclear cell proliferation

Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation.

IL12A

GO:0032956

BP

regulation of actin cytoskeleton organization

Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.

ROCK2, PDGFA, PDGFRB, RHOQ, PAM, EPHA3, CORO1A, EFNA5, EPHA5, RHOA, TGFB2, PRKCD, BST2, ARHGEF5, ILK, GPM6B, DIXDC1, FSCN1, CCDC88A, TWF2, RICTOR, ARHGAP18, DLC1, MLST8, SH3BGRL3

GO:0032957

BP

inositol trisphosphate metabolic process

The chemical reactions and pathways involving myo-inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached.

ITPK1

GO:0032958

BP

inositol phosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.

FGF2, PPIP5K1

GO:0032959

BP

inositol trisphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of inositol trisphosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached.

PLCG2, PTAFR

GO:0032962

BP

positive regulation of inositol trisphosphate biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.

LHCGR, HRH1, GPER1

GO:0032963

BP

collagen metabolic process

The chemical reactions and pathways involving collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).

TNXB, ID1, HIF1A, TNS2, P3H2

GO:0032964

BP

collagen biosynthetic process

The chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).

COL1A1, COL5A1, SERPINH1, TRAM2

GO:0032966

BP

negative regulation of collagen biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.

IL6, PPARG, RAP1A, PPARD, CYGB, ERRFI1

GO:0032967

BP

positive regulation of collagen biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.

F2, TGFB1, PDGFRB, BMP4, CCL2, ITGA2, F2R, CTGF, HDAC2, RGCC

GO:0032968

BP

positive regulation of transcription elongation from RNA polymerase II promoter

Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.

BRD4, GTF2F2, GTF2F1, TCEB1, SUPT6H, RTF1

GO:0032970

BP

regulation of actin filament-based process

Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the actin cytoskeleton.

FRMD6

GO:0032976

BP

release of matrix enzymes from mitochondria

The process in which enzymes, such as aspartate aminotransferase, are enabled to move from the mitochondrial matrix into the cytosol, as part of the apoptotic process.

BAX

GO:0032981

BP

mitochondrial respiratory chain complex I assembly

The aggregation, arrangement and bonding together of a set of components to form mitochondrial respiratory chain complex I.

NDUFS8, NDUFAB1, NDUFA1, NDUFS4, NDUFA2, NDUFS2, NDUFS6, NDUFB6, NDUFB4, NDUFB8, NDUFA7, NDUFA10, NDUFB10, NDUFB7, NDUFV2, NDUFS1, NDUFV3, NDUFA5, NDUFAF6, NDUFAF5, NDUFA11, NDUFAF2, NUBPL, NDUFAF3, TIMM21, TIMMDC1, NDUFB11, NDUFAF4, NDUFA13, BCS1L

GO:0033003

BP

regulation of mast cell activation

Any process that modulates the frequency, rate, or extent of mast cell activation.

PLSCR1, LYN

GO:0033004

BP

negative regulation of mast cell activation

Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.

CNR1

GO:0033025

BP

regulation of mast cell apoptotic process

Any process that modulates the frequency, rate, or extent of mast cell apoptotic process.

ADAM17

GO:0033026

BP

negative regulation of mast cell apoptotic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell apoptotic process.

KITLG

GO:0033030

BP

negative regulation of neutrophil apoptotic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of neutrophil apoptotic process.

CXCR2

GO:0033031

BP

positive regulation of neutrophil apoptotic process

Any process that activates or increases the frequency, rate, or extent of neutrophil apoptotic process.

ANXA1

GO:0033032

BP

regulation of myeloid cell apoptotic process

Any process that modulates the frequency, rate, or extent of myeloid cell apoptotic process.

THRA, PTEN

GO:0033033

BP

negative regulation of myeloid cell apoptotic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of a myeloid cell apoptotic process.

APOH, BCL2, MIF, MAEA

GO:0033034

BP

positive regulation of myeloid cell apoptotic process

Any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process.

ADIPOQ

GO:0033037

BP

polysaccharide localization

Any process in which a polysaccharide is transported to, or maintained in, a specific location.

CHST11

GO:0033043

BP

regulation of organelle organization

Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of an organelle.

SEC22B, CAMSAP2, CAMSAP3

GO:0033044

BP

regulation of chromosome organization

Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a chromosome.

CENPV

GO:0033058

BP

directional locomotion

Self-propelled movement of a cell or organism from one location to another along an axis.

GRIN2A, ARPIN

GO:0033059

BP

cellular pigmentation

The deposition or aggregation of coloring matter in a cell.

POMC

GO:0033076

BP

isoquinoline alkaloid metabolic process

The chemical reactions and pathways involving isoquinoline alkaloids, alkaloid compounds that contain bicyclic N-containing aromatic rings and are derived from a 3,4-dihydroxytyramine (dopamine) precursor that undergoes a Schiff base addition with aldehydes of different origin.

TH, CYP2D6

GO:0033077

BP

T cell differentiation in thymus

The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.

FZD7, GLI3, BCL2, RAG1, CTNNB1, ZFP36L2, STAT5B, B2M, RPS6, PRKDC, ADAM17, CDK6, ZFP36L1, FADD, JMJD6, NKAP, FZD8, MAFB

GO:0033081

BP

regulation of T cell differentiation in thymus

Any process that modulates the frequency, rate or extent of T cell differentiation in the thymus.

CLPTM1, ZEB1, SOS1

GO:0033085

BP

negative regulation of T cell differentiation in thymus

Any process that stops, prevents, or reduces the frequency, rate or extent of T cell differentiation in the thymus.

BMP4

GO:0033087

BP

negative regulation of immature T cell proliferation

Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation.

GNRH1

GO:0033088

BP

negative regulation of immature T cell proliferation in thymus

Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation in the thymus.

KIAA0922, ERBB2, BMP4

GO:0033089

BP

positive regulation of T cell differentiation in thymus

Any process that activates or increases the frequency, rate or extent of T cell differentiation in the thymus.

VNN1, ADA, GLI2, IL7R, ADAM8, EGR3

GO:0033091

BP

positive regulation of immature T cell proliferation

Any process that activates or increases the frequency, rate or extent of immature T cell proliferation.

RIPK2

GO:0033092

BP

positive regulation of immature T cell proliferation in thymus

Any process that activates or increases the frequency, rate or extent of immature T cell proliferation in the thymus.

FOXP3

GO:0033108

BP

mitochondrial respiratory chain complex assembly

The aggregation, arrangement and bonding together of a set of components to form a mitochondrial respiratory chain complex.

TFAM, SAMM50

GO:0033119

BP

negative regulation of RNA splicing

Any process that stops, prevents, or reduces the frequency, rate or extent of RNA splicing.

PTBP3, PTBP1, RPS13, RPS26, PTBP2

GO:0033120

BP

positive regulation of RNA splicing

Any process that activates or increases the frequency, rate or extent of RNA splicing.

ZPR1, ERN1, POLR2A, PIK3R1, SRSF1, SRSF5, SETX, RBM22

GO:0033128

BP

negative regulation of histone phosphorylation

Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein.

H2AFY, UBE2B, TWIST1

GO:0033129

BP

positive regulation of histone phosphorylation

Any process that activates or increases the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein.

RPS6KA5, IL1B, CCNB1, MAPK3, FMR1

GO:0033132

BP

negative regulation of glucokinase activity

Any process that stops, prevents, or reduces the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.

PARK2, RANBP2, MIDN, COX11

GO:0033133

BP

positive regulation of glucokinase activity

Any process that activates or increases the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.

PFKFB2, PFKFB1, BAD

GO:0033135

BP

regulation of peptidyl-serine phosphorylation

Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-serine.

PLCL1, RICTOR, SPTBN4, PLCL2

GO:0033136

BP

serine phosphorylation of STAT3 protein

The process of introducing a phosphate group to a serine residue of the STAT3 protein.

CDK5, NLK

GO:0033137

BP

negative regulation of peptidyl-serine phosphorylation

Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine.

SMAD7, DKK1, DMD, HGF, PPM1F, RACK1, CAV1, BAX, PDE4D, CNKSR3, INPP5K, DDIT4

GO:0033138

BP

positive regulation of peptidyl-serine phosphorylation

Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.

HAX1, AXIN1, RIPK2, SPRY2, CREBL2, PPP1R15A, BCAR3, LATS1, TGFB1, GCG, TNF, RAF1, IL6, BCL2, TXN, MIF, HCLS1, LIF, VEGFA, CD44, IL11, ATP2B4, AKT1, SNCA, WNT5A, PIK3CA, GSK3B, CDC42, CAV1, STK4, CAMK1, GAS6, PRKD1, ANGPT1, NTRK2, FNIP1, DOCK7, PDCD10, PINK1, PRKD2, TRIM6, SMYD3, FNIP2, TBK1

GO:0033141

BP

positive regulation of peptidyl-serine phosphorylation of STAT protein

Any process that activates or increases the frequency, rate or extent of the phosphorylation of a serine residue of a STAT (Signal Transducer and Activator of Transcription) protein.

IFNA1 , IFNA16, LIF, IFNE

GO:0033144

BP

negative regulation of intracellular steroid hormone receptor signaling pathway

Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.

CALR, NR0B1

GO:0033146

BP

regulation of intracellular estrogen receptor signaling pathway

Any process that modulates the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.

UFM1, CARM1, UBA5, UFSP2

GO:0033147

BP

negative regulation of intracellular estrogen receptor signaling pathway

Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.

CNOT1, BRCA1, STRN3, KANK2, CRIPAK, PHB2

GO:0033148

BP

positive regulation of intracellular estrogen receptor signaling pathway

Any process that activates or increases the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.

PARP1, AR, DDX5, SKP2, DDX17, PAGR1

GO:0033151

BP

V(D)J recombination

The process in which immune receptor V, D, and J, or V and J gene segments, depending on the specific receptor, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).

HMGB1, RAG1, HMGB2, DCLRE1C

GO:0033152

BP

immunoglobulin V(D)J recombination

The process in which immunoglobulin gene segments are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS). For immunoglobulin heavy chains V, D, and J gene segments are joined, and for immunoglobulin light chains V and J gene segments are joined.

TCF3, PRKDC

GO:0033153

BP

T cell receptor V(D)J recombination

The process in which T cell receptor V, D, and J, or V and J gene segments, depending on the specific locus, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).

PRKDC

GO:0033157

BP

regulation of intracellular protein transport

Any process that modulates the frequency, rate or extent of the directed movement of proteins within cells.

LCP1, SH3TC2, NDEL1, ATP13A2

GO:0033158

BP

regulation of protein import into nucleus, translocation

Any process that modulates the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane.

TXN, CDKN1A

GO:0033159

BP

negative regulation of protein import into nucleus, translocation

Any process that stops, prevents or reduces the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane.

GAS6

GO:0033160

BP

positive regulation of protein import into nucleus, translocation

Any process that activates or increases the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane.

JAK2, UBR5, IGF1, IL6, CDK1, HSP90AA1, HSP90AB1, MAVS

GO:0033168

BP

conversion of ds siRNA to ss siRNA involved in RNA interference

The process in which double-stranded siRNA molecules are converted to single-stranded siRNAs; required for the formation of a mature RITS complex during RNA interference.

DICER1

GO:0033169

BP

histone H3-K9 demethylation

The modification of histone H3 by the removal of a methyl group from lysine at position 9 of the histone.

KDM1A, JMJD1C, KDM7A

GO:0033173

BP

calcineurin-NFAT signaling cascade

Any intracellular signal transduction in which the signal is passed on within the cell by activation of a member of the NFAT protein family as a consequence of NFAT dephosphorylation by Ca(2+)-activated calcineurin. The cascade begins with calcium-dependent activation of the phosphatase calcineurin. Calcineurin dephosphorylates multiple phosphoserine residues on NFAT, resulting in the translocation of NFAT to the nucleus. The cascade ends with regulation of transcription by NFAT. The calcineurin-NFAT cascade lies downstream of many cell surface receptors, including G-protein coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) that signal to mobilize calcium ions (Ca2+).

NFATC1, RCAN1, PPP3CA, NFATC2, NFATC4

GO:0033184

BP

positive regulation of histone ubiquitination

Any process that activates or increases the frequency, rate or extent of the addition of a ubiquitin group to a histone protein.

KDM1A

GO:0033189

BP

response to vitamin A

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus.

ALDH1A2, CYP1A1, TYMS, PPARG, GATA4, HAMP, PPARD, PITX2, DNMT3B

GO:0033194

BP

response to hydroperoxide

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroperoxide stimulus. Hydroperoxides are monosubstitution products of hydrogen peroxide, HOOH.

JAK2, GPX1, STX2, STX4

GO:0033197

BP

response to vitamin E

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin E stimulus.

ADA, ALAD, LEP, SRSF2, HMGCS1, MEF2C

GO:0033198

BP

response to ATP

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus.

IL1B, HSPD1, SELL, CASP1, PTEN, TRPC3, KCNJ11, PANX1, P2RX4

GO:0033206

BP

meiotic cytokinesis

A cell cycle process that results in the division of the cytoplasm of a cell after meiosis, resulting in the separation of the original cell into two daughter cells.

ACTR3, ACTR2